Food and Drug Administration of Taiwan has notified medical institutions and pharmacies in Taiwan to immediately stop the supply and resume the collection of certain batches of Losartan. Losartan is a prescription medicine that is used to treat high blood pressure.
A total of 11 batches of Losartan have been recalled as part of this action.
The cancer-causing substance which was found in the medicine is called N-nitrosodiethylamine (NDEA). NDEA occurs naturally and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC).
NDEA is a naturally found impurity that is present in drinking water and some of the food items. It is also present in air pollution and industrial processes and can cause cancer according to the International Agency for Research on Cancer (IARC).
This is not the first recall of a blood pressure drug. Several others were also recalled, including 2 batches manufactured by Torrent Pharmaceuticals, during the previous months because they did not pass the evaluations conducted by the US FDA.
Losartan is a prescription medicine that is used to treat high blood pressure. This medicine works by preventing the activity of certain natural substances that tighten the blood vessels. This medicine helps by making blood flowing smoothly and the heart to pump more effectively.
Losartan belongs to the Angiotensin 2 Receptor Blocker class of medicines. Angiotensin II receptor blockers are used for the treatment of high blood pressure and heart failure.
These medicines act by relaxing the blood vessels and makes it easier for your heart to pump blood.